Nuclear translocation of SLC25A10 isoform 3 promotes chemoresistance in HCC cells via CEBPB/BCL2A1 signaling. [PDF]
Liu D +9 more
europepmc +1 more source
This study presents a comprehensive evaluation of Hibiscus sabdariffa L. calyx extracts from Libya, integrating phytochemical profiling, multi‐target biological activities, and in silico validation. Aqueous and ethanolic extracts were prepared and assessed for antibacterial activity against multidrug‐resistant clinical isolates (MIC: 6.25–25 mg/mL; MBC/
Ahmed Saeed Kabbashi +8 more
wiley +1 more source
Biomarker-driven maintenance therapy in extensive-stage-small cell lung cancer: evaluating the SWOG S1929 clinical trial. [PDF]
Johnston T, Breadner D, Raphael J.
europepmc +1 more source
Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion
Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Marllon Cindra Sant'Ana +8 more
wiley +1 more source
Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells. [PDF]
Däubler C +11 more
europepmc +1 more source
ABSTRACT Introduction Although prostate‐specific antigen (PSA) screening has facilitated early detection of prostate cancer, approximately 5% of patients still present with distant metastases at diagnosis. Ureteral metastasis from prostate cancer is extremely rare.
Hiroshi Ushida +3 more
wiley +1 more source
Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study. [PDF]
Dinc Sonusen S +14 more
europepmc +1 more source
Initial Dose Tarlatamab–Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report
We report a fatal case of acute TLS following a single 1‐mg dose of tarlatamab in a patient with relapsed SCLC with extensive liver metastases. This case highlights the importance of TLS risk assessment prior to tarlatamab treatment. Extensive liver metastases and elevated lactate dehydrogenase levels may be risk factors for TLS in patients with SCLC ...
Katsuhiko Shibata +8 more
wiley +1 more source
A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review. [PDF]
Kotian N, Reddy Y, Pai P, Sundara BK.
europepmc +1 more source
This prospective study quantitatively evaluates the phenomenon of hair repigmentation in patients with thoracic tumors undergoing immunotherapy. Using standardized trichoscopy and grayscale analysis, we observed a significant darkening of hair color following treatment with PD‐1/PD‐L1 inhibitors.
Sitong Jiang +7 more
wiley +1 more source

